Skip to main content
. Author manuscript; available in PMC: 2012 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):371–379. doi: 10.1097/QAI.0b013e3182237e54

Figure 2. Higher plasma sCD14 levels are associated with global T scores indicating neurocognitive impairment.

Figure 2

Subjects were grouped by global T <40 or ≥40 to compare biomarker levels. Only plasma sCD14 levels were significantly different between subjects with versus without impaired global T scores (second row, first panel), and correlated negatively with global T scores (second row, last panel). (VL, viral load). Median values are indicated as horizontal lines. Statistical significance between groups was calculated using the two-tailed Mann-Whitney test, and significance among continuous variables was calculated using Spearman rho correlation; significant differences (p<0.05) are indicated.